Question 1

Am I a good candidate for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the PS-002 for the Treatment of IgA Nephropathy in Adults clinical trial (NCT07182227). Contact the study team or your healthcare provider for specific answers.

Question 2

What potential side effects should I be aware of with PS-002?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the PS-002 for the Treatment of IgA Nephropathy in Adults clinical trial (NCT07182227). Contact the study team or your healthcare provider for specific answers.

Question 3

How does this treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the PS-002 for the Treatment of IgA Nephropathy in Adults clinical trial (NCT07182227). Contact the study team or your healthcare provider for specific answers.

Question 4

What will the follow-up process look like after I receive the treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the PS-002 for the Treatment of IgA Nephropathy in Adults clinical trial (NCT07182227). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any specific tests or procedures I need to complete before starting the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the PS-002 for the Treatment of IgA Nephropathy in Adults clinical trial (NCT07182227). Contact the study team or your healthcare provider for specific answers.

What this study is about